以岭万洲国际制药有限公司

以岭万洲国际制药有限公司

河北省石家庄市高新区以岭健康城西门

2014

500以上

50,000,000至54,999,999

以岭万洲国际制药有限公司是石家庄以岭药业股份有限公司的全资子公司，承担了三大业务板块中化生药物板块的发展重任。 以岭药业由中国工程院院士吴以岭于1992年创立，2011年上市。现有员工超过16,000人，在全球拥有多家分子公司。以岭已经发展成为年销售收入超过100亿元人民币，市值超过400亿元人民币的综合性制药企业。 以岭万洲拥有一支国际化的研发、质量、生产、营销团队、高层管理者均具有长期跨国制药公司任职背景和卓越经验，打造了可高效运行的管理体系，并且拥有创新**、坚实基及丰富经验的技术、生产团队。 以岭万洲致力于化生药物的海内外市场拓展，当前共有三个生产基地，涵盖原料药、制剂生产，所有车间均按照国际一流cGMP标准设计，引进国内外先进的自动化制药设备。建立了抗肿瘤药物、缓控释制剂、注射剂研发和转移平台，目前完成了三十多个技术转移项目、十余个临床试验用小批量新药生产项目、十三个自主知识产权的ANDA项目。 当前制剂生产场地综合生产能力达到64亿片/粒,近期将新增至264亿片/粒；且在持续增加注射剂产能。

品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,合同定制,接受买家的规格要求,接受小额订单,良好的信誉,优质服务

50035

<p> <strong>1临床样品加工</strong></p> <p> <strong>Contract Manufacture of clinical trial batches</strong></p> <p> 为您生产用于临床试验的产品（包括高活性和抗癌类产品）</p> <p> Produce batches for your clinical study (Ordinary, Anti-cancer and High potent products)</p> <p> 完全符合欧盟，美国cGMP的10万级洁净车间</p> <p> Small scale production plant fully compliant to cGMP (EU GMP and US FDA)</p> <p> 卓越的工艺放大技术和经验</p> <p> Unrivalled expertise in batch scaling up.</p> <p> 从实验室到市场，为您提供全面的支持</p> <p> Ideal partner to take your product from lab to the market</p> <p>  </p> <p> <strong>2  合同加工</strong></p> <p> <strong>CMO service</strong></p> <p> 固体口服制剂车间拥有世界主流国家的GMP认证，提供合同加工服务</p> <p> Oral solid dosage contract manufacture with worldwide GMP certification</p> <p> 中国MNPA GMP认证   Chinese MNPA  2009     </p> <p> 新西兰GMP认证  New Zealand 2009      </p> <p> 英国GMP认证    UK MHRA 2010 and 2012    </p> <p> 加拿大GMP认证  Canada Health Canada 2011          </p> <p> 澳大利亚GMP认证  Australia TGA 2011</p> <p>  </p> <p> 以岭产品出口至英国，德国，新西兰，加拿大，澳大利亚等国。</p> <p> Yiling is currently providing contract manufacturing service to UK, Germany, New Zealand, Canada,  Australia clients.</p> <p>  </p> <p> <strong>3 自有批文产品</strong></p> <p> <strong>Yiling UK MAs</strong></p> <p> 寻找商业合作伙伴在其他国家销售以岭在英国批准的产品</p> <p> Looking for partners to market our own UK licensed products in other countries</p> <p>  </p> <p>  </p> <table align="center" border="0" cellpadding="0" cellspacing="0" style="width: 82.26%;" width="82%"> <tbody> <tr> <td nowrap="nowrap" style="width: 38.14%; height: 22px;"> <p align="left"> <strong>Product name</strong></p> </td> <td nowrap="nowrap" style="width: 22.9%; height: 22px;"> <p align="left"> <strong>Tablet/capsule</strong></p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> <strong>Strength</strong></p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> <strong>Packaging</strong></p> </td> </tr> <tr> <td style="width: 38.14%; height: 33px;"> <p align="left"> Paroxetine Hydrochloride</p> </td> <td nowrap="nowrap" style="width: 22.9%; height: 33px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 33px;"> <p align="left"> 20mg</p> </td> <td style="width: 23.4%; height: 33px;"> <p align="left"> 30tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" rowspan="4" style="width: 38.14%; height: 22px;"> <p align="left"> Simvastatin</p> </td> <td nowrap="nowrap" rowspan="4" style="width: 22.9%; height: 22px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 10mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 20mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 40mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 80mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" rowspan="3" style="width: 38.14%; height: 22px;"> <p align="left"> Enalapril</p> </td> <td nowrap="nowrap" rowspan="3" style="width: 22.9%; height: 22px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 5mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 10mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 15.56%; height: 22px;"> <p align="left"> 20mg</p> </td> <td style="width: 23.4%; height: 22px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" rowspan="3" style="width: 38.14%; height: 25px;"> <p align="left"> Pravastatin</p> </td> <td nowrap="nowrap" style="width: 22.9%; height: 25px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 25px;"> <p align="left"> 10mg</p> </td> <td style="width: 23.4%; height: 25px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 22.9%; height: 25px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 25px;"> <p align="left"> 20mg</p> </td> <td style="width: 23.4%; height: 25px;"> <p align="left"> 28tablets/carton</p> </td> </tr> <tr> <td nowrap="nowrap" style="width: 22.9%; height: 25px;"> <p align="left"> Tablet</p> </td> <td nowrap="nowrap" style="width: 15.56%; height: 25px;"> <p align="left"> 40mg</p> </td> <td style="width: 23.4%; height: 25px;"> <p align="left"> 28tablets/carton</p> </td> </tr> </tbody> </table> <div style="clear: both;">  </div>

以岭万洲国际制药有限公司是石家庄以岭药业股份有限公司的全资子公司，其母公司以岭药业由中国工程院院士吴以岭于1992年创立，2011年上市。

制造商,代理商,贸易公司

北美洲,西欧,东欧,大洋洲,亚洲,中东

Tert-Butyl6-[(1E)-2-[4-(4-fluorophenyl) -6-(1-methylethyl)-2-[methyl (methylsulfonyl)amino]-5-pyrimid;4-(4-Fluorophenyl)-6-isopropyl-2- [(N-methyl-n-methylsulfonyl) amino]pyrimidine-5-yl-methanol;2-Butyl-4-spirocyclopentane-2- imidazolin-5-one hydrochloride;Ethyl (3R,4R,5S)-4-N-Acetylamino-5-N, N-diallylamino-3-(1-ethylpropoxy)-1- cyclohexene-1-carboxylate;4'-Methyl-2-cyanobiphenyl;N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl] -methyl ester L-valine monohydrochloride;(4S)-3-[5-(4-Fluorophenyl)-1,5- dioxopenyl]-4-phenyl-2-oxazolidinone;Letrozole;Anastrozole;Irbesartan;Telmisartan;Metoprolol Tartrate;Rivaroxaban;Oseltamivir phosphate;Dapagliflozin;Lenalidomide;Memantine Hydrochloride;L-carnitine;Alpha Lipoic acid;Levetiracetam;Pregabalin;Relugolix;Cabozantinib S-malate;Imatinib Mesylate;Pomalidomide;Lenvatinib;Apixaban;Olmesartan Medoxomil;Tenofovir Alafenamide Fumarate;Ticagrelor;Tadalafil;Canagliflozin;Tranexamic Acid;Tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2, 2-dimethyl-1,3-dioxane-4-acetate;（R）-3-Amino-1-butanol;Lamotrigine ER Tablets;Valacyclovir Tablets;Felodipine ER Tablets;Anastrozole Tablets;Acyclovir Tablets;Acyclovir Capsules;Letrozole Tablets;Ciprofloxacin Hydrochloride Tablets;Celecoxib Capsules;Lisinopril Tablets;Paroxetine Tablets;Buspirone HCL Tablets;FDF CDMO/CMO;API CDMO/CMO;Pilot and Clinical (Phase I-III) Batches;Commercial Batches;Formulation and process optimization;Analytical Method Development and Validation;Regulated Market Registration;Synthetic Route Development and Optimization;Analysis Method Development and Validation;Pilot Batches;Commercial Batches;Registration Support;OEM

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E3A02

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Excipients & Drug Formulation;Natural Extracts;Finished Dosage;CMO & CRO